Literature DB >> 15145601

Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices.

Beáta Sperlágh1, Mária Baranyi, György Haskó, E Sylvester Vizi.   

Abstract

In this study the effect of IL-1 beta on [(3)H]purine release from rat hippocampal slices was explored. IL-1 beta (3 x 10(-18)-3 x 10(-14) M) concentration-dependently elevated the basal [(3)H]purine efflux, and this effect was reversed by the selective IL-1RI receptor antagonist IL-1ra (10(-12) M). HPLC analysis revealed that the amount of [(3)H]ATP and [(3)H]adenosine significantly increased in the effluent in response to IL-1 beta. The sodium channel inhibitor tetrodotoxin, the NMDA and non-NMDA receptor antagonists d(-)-2-amino-5-phosphonopentanoic acid (AP-5) plus 6-cyano-7-nitroquinoxaline-2,3-dione-disodium (CNQX) almost completely abolished IL-1 beta-evoked [(3)H]purine release. The effect of IL-1 beta on [(3)H]purine efflux was also prevented by the p38 MAP kinase inhibitor SB 203580, by the nucleoside transport inhibitor nitrobenzyl-thioinosine (NBTI) and by low temperature (4 degrees C). In summary IL-1 beta triggers a transporter mediated [(3)H]purine efflux in the hippocampus which is conveyed by glutamate receptor activation and the p38 MAP kinase pathway, and could serve as a mediator of IL-1 beta-induced synaptic depression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145601     DOI: 10.1016/j.jneuroim.2004.02.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

1.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 3.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

4.  Augmented generation of protein fragments during wakefulness as the molecular cause of sleep: a hypothesis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2012-11       Impact factor: 6.725

5.  Interleukin-1 inhibits putative cholinergic neurons in vitro and REM sleep when microinjected into the rat laterodorsal tegmental nucleus.

Authors:  Dario Brambilla; Isabella Barajon; Susanna Bianchi; Mark R Opp; Luca Imeri
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

6.  Peripheral interleukin-1ß levels are elevated in chronic tension-type headache patients.

Authors:  Chris Della Vedova; Stuart Cathcart; Alan Dohnalek; Vanessa Lee; Mark R Hutchinson; Maarten A Immink; John Hayball
Journal:  Pain Res Manag       Date:  2013-08-16       Impact factor: 3.037

7.  Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.

Authors:  Meaghan Stolk; Elizabeth Cooper; Greg Vilk; David W Litchfield; James R Hammond
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

8.  Long-term potentiation is impaired in middle-aged rats: regional specificity and reversal by adenosine receptor antagonists.

Authors:  Christopher S Rex; Enikö A Kramár; Laura L Colgin; Bin Lin; Christine M Gall; Gary Lynch
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

Review 9.  CD39 and CD73 in immunity and inflammation.

Authors:  Luca Antonioli; Pál Pacher; E Sylvester Vizi; György Haskó
Journal:  Trends Mol Med       Date:  2013-04-17       Impact factor: 11.951

Review 10.  How (and why) the immune system makes us sleep.

Authors:  Luca Imeri; Mark R Opp
Journal:  Nat Rev Neurosci       Date:  2009-02-11       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.